Moderna Drops After Losing Appeal Over Drug-Delivery Patents (2)
Michael Hogan, PhD
Frontiers | The Limitless Future of RNA Therapeutics
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice - ScienceDirect
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines | ACS Central Science
Nanotechnology for COVID-19: Therapeutics and Vaccine Research | ACS Nano
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development | ACS Central Science
Machine Learning for Designing Next-Generation mRNA Therapeutics | Accounts of Chemical Research
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
Michael Hogan, Ph.D. - Vice-President for PepsiCo Foods North America Procurement - PepsiCo | LinkedIn
Michael Hogan - Postdoctoral Research Fellow - Children's Hospital of Philadelphia | LinkedIn
Michael Hogan, Ph.D. - Vice-President for PepsiCo Foods North America Procurement - PepsiCo | LinkedIn
Frontiers | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic - Wang - 2022 - Exploration - Wiley Online Library
Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement | ACS Nano
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability | npj Vaccines
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action | npj Vaccines
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability - ScienceDirect
Michael Hogan - Co-Founder & Chief Scientific Officer @ PathogenDx - Crunchbase Person Profile
Biomolecules | Free Full-Text | Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement
Machine Learning for Designing Next-Generation mRNA Therapeutics | Accounts of Chemical Research
Vaccines | Free Full-Text | Nanomaterial Delivery Systems for mRNA Vaccines
